Sawyer & Company’s Zimmer Biomet ZBH Stock Holding History

Sawyer & Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$1.8K	–	215
2025 Q4	$1.8K	Buy	+20	New	+$1.9K	﹤0.01%	198
2021 Q2	–	Sell	-82	Closed	-$13K	–	180
2021 Q1	$13K	Buy	+82	New	+$12.7K	0.01%	146

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sawyer & Company's ZBH Position: Q1 2026 in Review

Sawyer & Company sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 20 shares — an estimated $1.8K sold.

Sawyer & Company first reported a position in ZBH in Q1 2021 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Sawyer & Company reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Sawyer & Company sold 20 Zimmer Biomet shares in Q1 2026, an estimated $1.8K.
Sawyer & Company first reported a position in Zimmer Biomet in Q1 2021 and held it in 2 quarters.
Sawyer & Company's Zimmer Biomet position peaked at $13K in Q1 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Sawyer & Company's 13F filing for Q1 2026, filed 23 Apr 2026.